Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP410221.RAt2V6kRAwOKmOX9FOwe7GIrndgOVYhlDbZVAHRF3UrLQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP410221.RAt2V6kRAwOKmOX9FOwe7GIrndgOVYhlDbZVAHRF3UrLQ130_assertion type Assertion NP410221.RAt2V6kRAwOKmOX9FOwe7GIrndgOVYhlDbZVAHRF3UrLQ130_head.
- NP410221.RAt2V6kRAwOKmOX9FOwe7GIrndgOVYhlDbZVAHRF3UrLQ130_assertion description "[We found that a large fraction of neuroblastoma biopsies, independently from the clinical stage and degree of tumor cell differentiation, expressed significant levels of NY-ESO-1 as assessed by reverse transcription-PCR and immunohistochemistry.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410221.RAt2V6kRAwOKmOX9FOwe7GIrndgOVYhlDbZVAHRF3UrLQ130_provenance.
- NP410221.RAt2V6kRAwOKmOX9FOwe7GIrndgOVYhlDbZVAHRF3UrLQ130_assertion evidence source_evidence_literature NP410221.RAt2V6kRAwOKmOX9FOwe7GIrndgOVYhlDbZVAHRF3UrLQ130_provenance.
- NP410221.RAt2V6kRAwOKmOX9FOwe7GIrndgOVYhlDbZVAHRF3UrLQ130_assertion SIO_000772 14583496 NP410221.RAt2V6kRAwOKmOX9FOwe7GIrndgOVYhlDbZVAHRF3UrLQ130_provenance.
- NP410221.RAt2V6kRAwOKmOX9FOwe7GIrndgOVYhlDbZVAHRF3UrLQ130_assertion wasDerivedFrom befree-20140225 NP410221.RAt2V6kRAwOKmOX9FOwe7GIrndgOVYhlDbZVAHRF3UrLQ130_provenance.
- NP410221.RAt2V6kRAwOKmOX9FOwe7GIrndgOVYhlDbZVAHRF3UrLQ130_assertion wasGeneratedBy ECO_0000203 NP410221.RAt2V6kRAwOKmOX9FOwe7GIrndgOVYhlDbZVAHRF3UrLQ130_provenance.